Skip to main content

Thorne HealthTech, Inc. (THRN)

NASDAQ: THRN · IEX Real-Time Price · USD
6.92 -0.94 (-11.96%)
Dec 2, 2021 4:00 PM EST - Market closed

Company Description

Thorne HealthTech is a science-driven wellness company pioneering innovative solutions and personalized approaches to health and well-being.

We have developed a subscription platform that seamlessly combines convenient and comprehensive testing methods, proprietary data, personalized wellness education and premium nutritional solutions to focus on the human body and its unique needs.

Our unique, vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that help individuals take a proactive approach to improve and maintain their health over their lifetime.

By combining our proprietary multi-omics database, artificial intelligence and digital health content with our science-backed nutritional supplements, we deliver a total system for wellness.

During the past ten years, we have evolved to become a transformative consumer brand, trusted by more than 3,000,000 customers, 42,000 healthcare professionals, thousands of professional athletes, more than 100 professional sports teams and 11 U.S. Olympic teams.

Thorne HealthTech, Inc.
CountryUnited States
Founded1984
IPO DateSep 23, 2021
IndustryPackaged Foods
SectorConsumer Defensive
Employees440
CEOPaul Jacobson

Contact Details

Address:
152 W. 57th Street
New York, NY 10019
United States
Phone929-251-6321
Websitethorne.com

Stock Details

Ticker SymbolTHRN
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
IPO Price$10.00
CIK Code1844280

Key Executives

NamePosition
Paul F. JacobsonCo-Founder, Chief Executive Officer and Director
William C. McCamyPresident
Thomas P. McKennaChief Operating Officer and Director
Scott S. WheelerChief Financial Officer
Scott R. HurthChief Technology Officer
Dr. Bodi Zhang M.D., MPH, Ph.D.Chief Science Officer
Kim R. PearsonGeneral Counsel
Michelle L. CrowChief Marketing Officer
Rob MonteleoneSenior Vice President of Professional Sales
Stephen M. Phipps ND, Ph.D.Chief Innovation Officer

Latest SEC Filings

DateTypeTitle
Nov 10, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 10, 20218-KCurrent report
Sep 29, 20214Statement of changes in beneficial ownership of securities
Sep 29, 20214Statement of changes in beneficial ownership of securities
Sep 29, 20214Statement of changes in beneficial ownership of securities
Sep 29, 20214Statement of changes in beneficial ownership of securities
Sep 28, 20213Initial statement of beneficial ownership of securities
Sep 28, 20213Initial statement of beneficial ownership of securities
Sep 28, 20214Statement of changes in beneficial ownership of securities
Sep 28, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings